Trials / Completed
CompletedNCT00638456
Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis
Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis, a Randomized Clinical Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Ranjan Dohil · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate whether or not oral viscous budesonide is effective in treating children with Eosinophilic Esophagitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Budesonide plus Prevacid | Budesonide is taken daily for three months. In addition, Prevacid is taken twice daily for three months. |
| DRUG | placebo plus Prevacid | Placebo is taken daily for three months. In addition, Prevacid is taken twice daily for three months. |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2008-03-19
- Last updated
- 2019-08-14
- Results posted
- 2019-08-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00638456. Inclusion in this directory is not an endorsement.